Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05081596 · ClinicalTrials.gov registry record · NA

A Primary Care-Based Psychosocial Intervention To Improve Cognitive & Depression Outcomes in Older Adults With MCI & Early Stage AD

A NA study of Depression and Pain, sponsored by Weill Medical College of Cornell University.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT05081596 is a NA study of Depression and Pain that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 100 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05081596, a NA study of Depression and Pain, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to examine the effect of Problem Adaptation Therapy for Pain (PATH-Pain) on cognitive functioning, depression and pain-related disability in 100 older adults with cognitive impairment, chronic pain, and depression. The study will test if PATH-Pain has better cognitive, affective, and functional outcomes than Attention Control Usual Care.

Interventions

  • BEHAVIORAL PATH-Pain

Study Locations (1)

New York

  • Weill Cornell Medicine - White Plains

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2022-06-03
Est. Completion 2027-07-31
Phase NA

What the Registry Record Tells You About NCT05081596

The ClinicalTrials.gov registry entry for NCT05081596 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (87% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which PATH-Pain is the first listed.

NCT05081596 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05081596 about?

NCT05081596 is a clinical study titled "A Primary Care-Based Psychosocial Intervention To Improve Cognitive & Depression Outcomes in Older Adults With MCI & Early Stage AD". The purpose of the study is to examine the effect of Problem Adaptation Therapy for Pain (PATH-Pain) on cognitive functioning, depression and pain-related disability in 100 older adults with cognitive impairment, chronic pain, and depression. The study will test if PATH-Pain has better cognitive, af...

What is the current status of trial NCT05081596?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2022-06-03. Estimated completion is 2027-07-31.

What conditions does trial NCT05081596 study?

This clinical trial studies the following conditions: Depression, Pain, Cognitive Impairment.

What interventions are being tested in trial NCT05081596?

The interventions under investigation include: PATH-Pain (BEHAVIORAL).

Who is sponsoring clinical trial NCT05081596?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05081596 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.